KAIST

< Photo of the Donation Agreement Ceremony > KAIST announced on March 11th that Inseo Chung (28), an undergraduate student in the School of Interdisciplinary Studies and CEO of the global music-tech startup MPAG, donated 1 billion won in development funds on the 10th to foster ‘Inclusive AI’ talent. Inclusive AI talent refers to experts who research and develop AI technologies so that the socially vulnerable, including people with disabilities and the technologically margi

<(From Left) Dr. Minju Jeong,(UCSD), Prof. Byung Kook Lim (UCSD), Prof. Se-Bum Paik (KAIST)> Drug addiction carries an extremely high risk of relapse, as cravings can be reignited by minor stimuli even long after one has stopped using. Previously, this phenomenon was attributed to a decline in the function of the prefrontal cortex (PFC), which regulates impulses. However, a joint international research team has recently revealed that the cause of addiction relapse is not a simple decli

< (From Left) M.S candidate Dongwon Lee from School of Electrical Engineering, Ph.D candidate Jaehun Han from Graduate School of Quantum Science and Technology > "Team Yangja-jorim," consisting of Dongwon Lee, Gyungjun Kim and Jaehun Han , has been honored with the Grand Prize at the '2026 2nd Global Quantum AI Competition.' The event was hosted and organized by NORMA, a specialized quantum computing company. This global competition was designed to expand hands-on experience with quant

< Group photo of meeting participants > KAIST announced on the 6th that the 'Jobs for Youth in Africa Knowledge Exchange' platform was held in Nairobi, Kenya, from March 3 to 5 (local time). The event was hosted by the Kenyan government and co-organized by the World Bank Group, the African Union, and the KAIST Global Center for Development and Strategy (G-CODEs). As a high-level policy implementation platform dedicated to addressing youth employment challenges in Africa, the event drew

<(From Left) Dr. Subin Yoon, Ph.D candidate Hyeonggon Cho, Prof. Jae-Hwan Nam, Prof. Young-suk Lee> Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA therapeutics work by delivering genetic instructions that enable cells to produce specific proteins for therapeutic effects. However, their efficacy has been reported to decline in elderly individuals or patients with obesity. To address this limitation, Korean researchers